Marshall Wace
MDGL icon

Marshall Wace’s Madrigal Pharmaceuticals MDGL Stock Holding History

Marshall Wace’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$54.7M Buy
101,859
+79,957
+365% +$41M 0.04% 345
2026
Q1 		$11.5M Sell
21,902
-17,676
-45% -$8.44M 0.01% 909
2025
Q4 		$23M Buy
39,578
+38,878
+5,554% +$19.9M 0.02% 586
2025
Q3 		$321K Sell
700
-54,419
-99% -$20.3M ﹤0.01% 2400
2025
Q2 		$16.7M Buy
55,119
+52,319
+1,869% +$15.6M 0.02% 656
2025
Q1 		$927K Sell
2,800
-14,694
-84% -$4.83M ﹤0.01% 1818
2024
Q4 		$5.4M Sell
17,494
-62,907
-78% -$17.7M 0.01% 1021
2024
Q3 		$17.1M Buy
80,401
+78,701
+4,629% +$20.1M 0.02% 566
2024
Q2 		$476K Buy
+1,700
New +$405K ﹤0.01% 1981
2024
Q1 		– Sell
-33,071
Closed -$7.65M – 2672
2023
Q4 		$7.65M Sell
33,071
-362,327
-92% -$63.4M 0.01% 763
2023
Q3 		$57.7M Sell
395,398
-65,246
-14% -$12.3M 0.12% 176
2023
Q2 		$106M Sell
460,644
-81,120
-15% -$22M 0.21% 94
2023
Q1 		$131M Buy
+541,764
New +$148M 0.28% 73
2022
Q1 		– Sell
-608
Closed -$52K – 3736
2021
Q4 		$52K Buy
+608
New +$50K ﹤0.01% 3549
2021
Q3 		– Sell
-98,180
Closed -$9.56M – 3264
2021
Q2 		$9.56M Buy
+98,180
New +$11.6M 0.04% 509
2020
Q1 		– Sell
-1,350
Closed -$123K – 1887
2019
Q4 		$123K Sell
1,350
-686
-34% -$66.5K ﹤0.01% 1423
2019
Q3 		$175K Buy
+2,036
New +$191K ﹤0.01% 1306
2019
Q2 		– Sell
-20,462
Closed -$2.56M – 1634
2019
Q1 		$2.56M Buy
+20,462
New +$2.54M 0.02% 664
2018
Q4 		– Sell
-19,808
Closed -$4.24M – 1719
2018
Q3 		$4.24M Buy
+19,808
New +$4.97M 0.04% 493

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace's MDGL Position: Q2 2026 in Review

Marshall Wace increased its Madrigal Pharmaceuticals (MDGL) stake by 365% in Q2 2026, buying an estimated $41M and bringing the position to 101,859 shares worth $54.7M. The position accounts for 0.04% of the portfolio, ranked #345.

Marshall Wace first reported a position in MDGL in Q3 2018 and has held it in 19 quarters since. The position peaked at $131M in Q1 2023. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Marshall Wace held 101,859 shares of Madrigal Pharmaceuticals worth $54.7M as of Q2 2026.
  • Marshall Wace bought 79,957 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $41M.
  • Madrigal Pharmaceuticals made up 0.04% of Marshall Wace's portfolio in Q2 2026, its #345 holding.
  • Marshall Wace first reported a position in Madrigal Pharmaceuticals in Q3 2018 and has held it in 19 quarters since.
  • Marshall Wace's Madrigal Pharmaceuticals position peaked at $131M in Q1 2023.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.